These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3919049)

  • 1. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.
    Fraser HM; Sandow J
    J Clin Endocrinol Metab; 1985 Mar; 60(3):579-84. PubMed ID: 3919049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral and not central suppression of ovarian function during osmotic pump infusion of adrenocorticotropin-(1-24) for one menstrual cycle in the cynomolgus monkey and its partial compensation by a transitory elevation of sex hormone-binding globulin levels.
    Kowalski W; Chatterton RT
    Endocrinology; 1992 Jun; 130(6):3582-92. PubMed ID: 1597155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gonadotrophin-releasing hormone agonist-induced suppression of LH and FSH on follicle growth and corpus luteum function in the ewe.
    McNeilly AS; Fraser HM
    J Endocrinol; 1987 Nov; 115(2):273-82. PubMed ID: 3125300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subchronic infusion of dehydroepiandrosterone sulfate on serum gonadotropin levels and ovarian function in the cynomolgus monkey.
    Kowalski W; Chatterton RT
    Fertil Steril; 1992 Apr; 57(4):912-20. PubMed ID: 1532562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
    Fraser HM; Lunn SF
    Hum Reprod; 1989 Jul; 4(5):506-12. PubMed ID: 2507574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides).
    Fraser HM; Abbott M; Laird NC; McNeilly AS; Nestor JJ; Vickery BH
    J Endocrinol; 1986 Oct; 111(1):83-90. PubMed ID: 3097236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
    Healy DL; Lawson SR; Abbott M; Baird DT; Fraser HM
    J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference in follicular maturation following acute intranasal LH-RH agonist administration during mid and late follicular phase.
    Lemay A; Faure N
    Int J Fertil; 1988; 33(1):60-7. PubMed ID: 2896176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of late follicular phase administration of antide on ovulation and inhibin secretion in macaques.
    Fraser HM; Lunn SF; Cowen GM; Smith KB; Conn PM
    Contraception; 1991 Dec; 44(6):667-76. PubMed ID: 1773623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of treatment with an LHRH antagonist on the ovulatory cycle are reduced when administered during the late follicular phase.
    Fraser HM
    Contraception; 1990 Jan; 41(1):73-83. PubMed ID: 2105873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase defects in the rhesus monkey: the significance of serum FSH:LH ratios.
    Wilks JW; Hodgen GD; Ross GT
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1261-7. PubMed ID: 826543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.